Patel AA - Search Results

1

Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.

Saygin C, Giordano G, Shimamoto K, Eisfelder B, Thomas-Toth A, Venkataraman G, Ananthanarayanan V, Vincent TL, DuVall A, Patel AA, Chen Y, Tan F, Anthony SP, Chen Y, Shen Y, Odenike O, Teachey DT, Kee BL, LaBelle J, Stock W. Saygin C, et al. Among authors: patel aa. Clin Cancer Res. 2023 Aug 15;29(16):3151-3161. doi: 10.1158/1078-0432.CCR-23-0415. Clin Cancer Res. 2023. PMID: 37363966 Free PMC article.

2

Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.

Patel AA, Cahill K, Charnot-Katsikas A, Liu H, Gurbuxani S, Thirman M, Kosuri S, Artz AS, Larson RA, Stock W, Segal J, Odenike O. Patel AA, et al. Br J Haematol. 2020 Jul;190(1):e48-e51. doi: 10.1111/bjh.16709. Epub 2020 May 1. Br J Haematol. 2020. PMID: 32358888 Free article. No abstract available.

3

Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults.

Patel AA, Thomas J, Rojek AE, Stock W. Patel AA, et al. Curr Treat Options Oncol. 2020 May 28;21(7):57. doi: 10.1007/s11864-020-00757-5. Curr Treat Options Oncol. 2020. PMID: 32468488 Review.

4

The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.

Patel AA, Odenike O. Patel AA, et al. Curr Hematol Malig Rep. 2020 Dec;15(6):409-418. doi: 10.1007/s11899-020-00596-z. Curr Hematol Malig Rep. 2020. PMID: 32780250 Review.

5

Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement.

Carll T, Patel A, Derman B, Hyjek E, Lager A, Wanjari P, Segal J, Odenike O, Fidai S, Arber D. Carll T, et al. Blood Adv. 2020 Oct 13;4(19):4924-4928. doi: 10.1182/bloodadvances.2019001282. Blood Adv. 2020. PMID: 33049052 Free PMC article.

6

Genomics of MPN progression.

Patel AA, Odenike O. Patel AA, et al. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):440-449. doi: 10.1182/hematology.2020000129. Hematology Am Soc Hematol Educ Program. 2020. PMID: 33275731 Free PMC article. Review.

7

Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies.

Patel AA, Cahill K, Saygin C, Odenike O. Patel AA, et al. Blood Adv. 2021 Apr 27;5(8):2264-2271. doi: 10.1182/bloodadvances.2020002929. Blood Adv. 2021. PMID: 33904891 Free PMC article. Review.

8

Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.

Patel AA, Heng J, Dworkin E, Monick S, Derman BA, DuVall AS, Gurbuxani S, Kosuri S, Liu H, Thirman M, Godley LA, Odenike O, Larson RA, Stock W. Patel AA, et al. EJHaem. 2021 Jun 22;2(3):413-420. doi: 10.1002/jha2.224. eCollection 2021 Aug. EJHaem. 2021. PMID: 35844676 Free PMC article.

9

Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.

Alban J, DuVall A, Gurbuxani S, Stock W, Patel AA. Alban J, et al. Among authors: patel aa. JCO Precis Oncol. 2022 Oct;6:e2200353. doi: 10.1200/PO.22.00353. JCO Precis Oncol. 2022. PMID: 36240471 Free PMC article. No abstract available.

10

Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.

Badar T, Litzow MR, Shallis RM, Patel A, Saliba AN, Burkart M, Bewersdorf JP, Stahl M, De Camargo Correia GS, Guru Murthy GS, Abaza Y, Duvall A, Bradshaw D, Kota V, Dinner S, Goldberg AD, Palmisiano N, Al Kali A, Atallah E. Badar T, et al. Cancer. 2023 Mar 15;129(6):934-945. doi: 10.1002/cncr.34604. Epub 2022 Dec 21. Cancer. 2023. PMID: 36545710 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

754 results

Search Page